Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment ofHelicobacter pyloriinfections
Authors:
- Maurício Palmeira Chaves de SouzaMSMaurício Palmeira Chaves de Souza
- Bruna Almeida Furquim de CamargoBCBruna Almeida Furquim de Camargo
- Larissa SpósitoLSLarissa Spósito
- Giovanna Capaldi FortunatoGFGiovanna Capaldi Fortunato
- Gabriela Corrêa CarvalhoGCGabriela Corrêa Carvalho
- Gabriel Davi MarenaGabriel Davi Marena
- Andréia Bagliotti MeneguinAMAndréia Bagliotti Meneguin
- Taís Maria BauabTBTaís Maria Bauab
- Marlus ChorilliMarlus Chorilli
- 16 March 2021
- journal article
- other
- Published by Taylor & Francis in Critical Reviews in Microbiology
- Vol. 47 (4) , 435-460
Abstract
Due to the high adaptability of Helicobacter pylori and the low targeting specificity of the drugs normally used in pharmacological therapy, the strains are becoming increasingly resistant to these drugs, making it difficult to eradicate the infection. Thus, the search for new therapeutic approaches has been considered urgent. The incorporation of drugs in advanced drug delivery systems, such as nano and microparticles, would allow the improvement of the retention time in the stomach and the prolongation of drug release rates at the target site. Because of this, the present review article aims to highlight the use of micro and nanoparticles as important technological tools for the treatment of H. pylori infections, focussing on the main nanotechnological systems, including nanostructured lipid carriers, liposomes, nanoemulsion, metallic nanoparticles, and polymeric nanoparticles, as well as microtechnological systems such as gastroretentive dosage forms, among them mucoadhesive, magnetic and floating systems were highlighted.Keywords
Funding Information
- Coordenação de Aperfeiçoamento Pessoal de nível Superior, Brasil
- Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESP (2019/09597-6)
This publication has 166 references indexed in Scilit:
- The Molecular Basis of Inactivation of Metronidazole-Resistant Helicobacter pylori Using Polyethyleneimine Functionalized Zinc Oxide NanoparticlesPLOS ONE, 2013
- Genipin-cross-linked fucose–chitosan/heparin nanoparticles for the eradication of Helicobacter pyloriBiomaterials, 2013
- Helicobacter pylori infection in functional dyspepsiaNature Reviews Gastroenterology & Hepatology, 2013
- A Novel Method for Genotyping the Helicobacter pylori vacA Intermediate Region Directly in Gastric Biopsy SpecimensJournal of Clinical Microbiology, 2012
- Green Synthesis of Silver Nanoparticles through Reduction with Solanum xanthocarpum L. Berry Extract: Characterization, Antimicrobial and Urease Inhibitory Activities against Helicobacter pyloriInternational Journal of Molecular Sciences, 2012
- Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProceedings of the National Academy of Sciences of the United States of America, 2011
- Physiological Parameters for Oral Delivery andin VitroTestingMolecular Pharmaceutics, 2010
- Preparation and Evaluation of Anti-Helicobacter pylori Efficacy of Chitosan Nanoparticles in Vitro and in VivoJournal of Biomaterials Science, Polymer Edition, 2009
- Presence of Helicobacter pylori in a Mexican Pre-Columbian MummyBMC Microbiology, 2008
- UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITISThe Lancet, 1983